| 27.01. | Hong Kong stocks ease ahead of China market reopening after Lunar New Year holiday |  |
| 26.01. | Hong Kong stocks hit 9-month high on lunar new year rush | |
| 19.01. | Sino Biopharmaceutical to Redeem Bonds of 487.6 Million Euros | |
| 19.01. | La actualización de la Lista Nacional de Medicamentos Reembolsables de China cumple las.. |  |
| 16.01. | Chinese Regulator Grants Marketing Approval to Akeso, Sino Biopharmaceutical's Lung Can.. | |
| 13.01. | China Accepts Sino Biopharmaceutical's Marketing Application for Lung Cancer Drug | |
| 13.01. | Sino Biopharmaceutical Limited Announces Application for Marketing of Category I Innova.. | |
| 11.01. | Sino Biopharmaceutical Unit Gets Exclusive Commercialization Rights for Denosumab Injec.. | |
| 03.01. | Sino Biopharmaceutical Unit to Exclusively Market PL-5 Peptide | |
| 02.01. | Sino Biopharmaceutical Gets Marketing Rights to COVID-19 Drug Ensitrelvir | |
| 2022 | Top Midday Gainers | |
| 2022 | F-Star Therapeutics Shares Erase Much of Thursday's Loss | |
| 2022 | F-star Therapeutics Extends invoX Deal Date to Help Address CFIUS Concerns; Shares Rise | |
| 2022 | Boan Biotechnology Raises HK$152.8 Million in Hong Kong IPO | |
| 2022 | Shandong Boan Biotechnology Seeks Up to HK$212 Million in Hong Kong IPO | |
| 2022 | Sino Biopharmaceutical Completes Patient Enrollment in Anti-Haemophilia Drug Trial | |
| 2022 | Sino Biopharmaceutical Limited Announces the Enrollment of All Patients in Phase III Cl.. | |
| 2022 | Sector Update: Health Care Stocks Advance Modestly | |
| 2022 | Sino Biopharmaceutical's Q3 Revenue Rises 21%; Shares Rise 5% | |
| 2022 | Sino Biopharmaceutical Limited Provides Revenue Guidance for 2023 | |
| 2022 | Sino Biopharmaceutical Limited Reports Unaudited Revenue Results for the Third Quarter .. | |
| 2022 | Sino Biopharmaceutical Limited Announces Resignation of Wang Shanchun as Executive Dire.. | |
| 2022 | Trustee Purchases Sino Biopharmaceutical Shares for $1.3 Million | |
| 2022 | Trustee Purchases 2,780,000 Sino Biopharmaceutical Shares for $1.3 Million | |
| 2022 | Chinese Regulator Approves Clinical Trial of Sino Biopharmaceutical's COVID-19 Medicine.. | |
| 2022 | Inventiva ADRs Rise 22% After Licensing Deal With Chia Tai-Tianqing Pharma | |
| 2022 | Chia Tai-Tianqing Signs Agreement for Lanifibranor | |
| 2022 | Sino Biopharmaceutical Trustee Purchases Shares for $1 Million | |
| 2022 | Sino Biopharmaceutical Trustee Purchases Additional $1 Million Shares | |
| 2022 | HanchorBio Inc. announced that it has received $10 million in funding from Zero2IPO Ven.. | |
| 2022 | Sino Biopharmaceutical Limited announces an Equity Buyback for 1,882,009,423 shares, re.. | |
| 2022 | China's CanSinoBIO H1 revenue drops on weaker COVID shot demand | |
| 2022 | Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to .. | |
| 2022 | Sino Biopharmaceutical Limited Announces Interim Cash Dividend for the period ended 30 .. | |
| 2022 | Sino Biopharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30.. | |
| 2022 | Hong Kong Hang Seng Up 0.5% As Property and Tech Sectors Edge Higher | |
| 2022 | Sino Biopharmaceutical CEO Resigns | |
| 2022 | Sino Biopharmaceutical Limited Announces Resignation of Li Yi as Executive Director | |
| 2022 | Sino Biopharmaceutical Limited Announces CEO Changes, Effective July 28, 2022 | |
| 2022 | Generon Corporation Ltd. announced that it has received $70.000203 million in funding f.. | |
| 2022 | Hong Kong Hang Seng Down 0.6% As Tech Issues Weaken | |
| 2022 | Sino Biopharmaceutical Submits Application for Marketing of Anti-Tumor Capsule | |
| 2022 | Sino Biopharmaceutical Limited Announces Application for Marketing of Category 1 Anti-T.. | |
| 2022 | Sino Biopharmaceutical to Buy Nasdaq-listed F-Star Therapeutics for $161 Million; Share.. | |
| 2022 | Sector Update: Health Care Stocks Lead Thursday Markets Recovery | |
| 2022 | Sector Update: Health Care Stocks Again Outpacing Other Sectors to the Ups.. | |
| 2022 | Sector Update: Health Care | |
| 2022 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Thursday | |
| 2022 | Sector Update: Health Care | |
| 2022 | F-star Therapeutics Shares Soar on Buyout Deal | |
| 2022 | Sino Biopharmaceutical Unit to Buy F-star Therapeutics for $161 Million | |
| 2022 | InvoX Pharma to Buy F-star Therapeutics in $161 Million Deal | |
| 2022 | Sino Biopharmaceutical Adjusts Conversion Price for Convertible Bonds | |
| 2022 | Sino Biopharmaceutical Obtains China Approval for Anti-Asthma Injectable Clinical Trial.. | |
| 2022 | Sino Biopharmaceutical Limited Announces Approval of Category 1 Innovative Drug TQC2938.. | |
| 2022 | SciClone Pharma Hires Former Sino Biopharma Exec as Chief Medical Officer; Shares Slide.. | |
| 2022 | Hong Kong Hang Seng Down 0.6% As Tech Rally Stalls | |
| 2022 | Sino Biopharmaceutical Limited's Equity Buyback announced on July 27, 2021, has expired.. | |
| 2022 | Generon Corporation Ltd. announced that it expects to receive $70 million in funding fr.. | |
| 2022 | China Accepts Sino Biopharm's Marketing Application for Cancer Drug | |
| 2022 | Sino Biopharm Buys Back $278 Million of Euro-Denominated Bonds | |
| 2022 | Sino Biopharmaceutical Submits Application for Marketing of the Category I Anti-Tumor I.. | |
| 2022 | Sino Biopharm Repurchases $168 Million of Euro-Denominated Bonds | |
| 2022 | Sino Biopharm Unit to Purchase Tumor Inhibitor of Danish Biotech Firm Symphogen | |
| 2022 | Hong Kong Stocks Rebound from Near Two-Month Low; Biotech Shares Rally | |
| 2022 | Sino Biopharm Repurchases $86.5 Million of Euro-Denominated Bonds | |
| 2022 | Sino Biopharmaceutical Signs License Deal for Hepatitis, Diabetes Drugs | |
| 2022 | Sino Biopharm Gets Clearance to Start China Clinical Trial of Anti-Tumor Drug | |
| 2022 | Sino Biopharmaceutical Limited's Category I Anti-Tumor Innovative Drug "TQB2930" Obtain.. | |
| 2022 | Sino Biopharmaceutical Limited Announces Anlotinib Hydrochloride Capsules Obtains Appro.. | |
| 2022 | Sino Biopharmaceutical's TQ-B3525 Drug Gets Breakthrough Therapy Drug Designation from .. | |
| 2022 | Chinese Drug Regulator Accepts Sino Biopharmaceutical's Respiratory Diseases Injection .. | |
| 2022 | Sino Biopharmaceutical Limited Announces Innovative Drug "TQ-B3525" Was Included in the.. | |
| 2022 | Sino Biopharmaceutical Limited Announces That Application for Clinical Trial of "TQC293.. | |
| 2022 | Sino Biopharm's New Product Launches Propel Profit by 427% in 2021 | |
| 2022 | Sino Biopharm Unveils Share Buyback, Boosts Dividend as 2021 Profit Soars 427% | |
| 2022 | Hong Kong Hang Seng Index Up 0.2% in Late Rally | |
| 2022 | Sino Biopharmaceutical Limited Proposes Final Dividend for the Final Dividend for 2021,.. | |
| 2022 | Sino Biopharmaceutical Limited Reports Earnings Results for the Full Year Ended Decembe.. | |
| 2022 | Chinese Regulators OK Sino Biopharma's Clinical Trial of Solid Tumor Treatment | |
| 2022 | Sino Biopharm Wins Nod to Start China Clinical Trial of Solid Tumor Drug | |
| 2022 | Sino Biopharmaceutical Limited Announces Category I Anti-Tumour Innovative Medicine FHN.. | |
| 2022 | Sino Biopharma Partners With Shenzhen XtalPi for Anti-Tumor Drug Development | |
| 2022 | Sino Biopharm's Drug for Overactive Bladder Wins Registration Approval in China; Shares.. | |
| 2022 | Sino Biopharmaceutical Limited Announces Mirabegron Sustained-Release Tablets Obtained .. | |
| 2022 | Sino Biopharm Sees Up to Fivefold Increase in 2021 Profit; Shares Jump 7% | |
| 2022 | Sino Biopharm's Antibiotic Wins Marketing Approval, Generic Status in China; Shares Ris.. | |
| 2022 | Sino Biopharmaceutical Limited Announces Linezolid Tablets Obtained Drug Registration C.. | |
| 2022 | Sino Biopharmaceutical Limited Provides Group Earnings Guidance for the Year Ended 31 D.. | |
| 2022 | US FDA OKs Sino Biopharma's Abbreviated NDA for Blood Lipid-Lowering Drug | |
| 2022 | Sino Biopharmaceutical Limited Announces Colesevelam Hydrochloride Tablets Obtained AND.. | |
| 2022 | China Approves Market Launch of Sino Biopharm's Antipsychotic Medication | |
| 2022 | Sino Biopharmaceutical Limited's Lurasidone Hydrochloride Tablets Obtains Drug Registra.. | |
| 2022 | Japanese Regulators Allow Sino Biopharma to Sell Anti-Rheumatic Drug | |
| 2022 | Sino Biopharma Arm Partners With Biocytogen Pharmaceuticals for Antibody Drugs Developm.. | |
| 2022 | Chinese Regulators Grant Drug Registration Certificate to Sino Bio's Generic Rheumatoid.. | |
| 2022 | Chinese Regulators Grant Drug Registration Certificates to Sino Bio's Generic Diabetes .. | |
| 2022 | Sino Biopharmaceutical Limited Announces Sitagliptin Phosphate Tablet | |
| 2022 | Sino Biopharmaceutical Limited Obtains Drug Registration Certificate | |
| 2022 | Sino Biopharm Wins Greenlight to Start China Clinical Trial of Pneumoconiosis Treatment.. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
